Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs. Morphine for Pain in Sickle Cell Disease
NCT01380197Phase 3Completed
- Sponsor
- Children's Healthcare of Atlanta
- Start
- May 2010
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of nalbuphine in sickle cell disease (SCD), sponsored by Children's Healthcare of Atlanta. Started May 2010; status: completed.
02
Drugs
nalbuphine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01380197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01380197.